UK Approves Novo's Weight-Loss Pill, Projecting Widespread Use by 2027

The Wegovy weight-loss pill has been approved for sale in the UK, with a study predicting that one in eight Britons will be taking the medication by 2027, influencing consumer spending habits.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

berlingskeDanish55d ago

I 2027 tager en af otte briter vægttabsmedicin efter OK til Novos slankepille

Wegovy-pillen, som netop er godkendt til salg i Storbritannien, vil få endnu flere til at skære ned på slikindkøbene og i stedet bruge flere penge på friske fødevarer, fitness – og tøj, viser stor undersøgelse.

Read full article →

PERSPECTA

PERSPECTA

UK Approves Novo's Weight-Loss Pill, Projecting Widespread Use by 2027

Sources

I 2027 tager en af otte briter vægttabsmedicin efter OK til Novos slankepille

Related Stories

Netflix Stock Valuation Debate: Undervalued or Value Trap?

Ferrari's First Electric Car, Luce, Sells for Record $40 Million at Auction

OpenAI Investors Consider Latest CFO Comments

Synchrony Partners with OpenAI for AI Shopping Integration

PERSPECTA